Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Non-Current Assets (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Non-Current Assets for 6 consecutive years, with $58.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 5.09% year-over-year to $58.5 million, compared with a TTM value of $232.4 million through Dec 2025, up 5.21%, and an annual FY2025 reading of $58.5 million, up 5.09% over the prior year.
  • Non-Current Assets was $58.5 million for Q4 2025 at Treace Medical Concepts, roughly flat from $58.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $58.8 million in Q2 2025 and bottomed at $929000.0 in Q1 2021.
  • Average Non-Current Assets over 5 years is $37.1 million, with a median of $52.4 million recorded in 2023.
  • The sharpest move saw Non-Current Assets surged 1966.63% in 2022, then rose 1.95% in 2025.
  • Year by year, Non-Current Assets stood at $2.8 million in 2021, then skyrocketed by 799.33% to $25.6 million in 2022, then surged by 108.99% to $53.5 million in 2023, then grew by 4.0% to $55.7 million in 2024, then increased by 5.09% to $58.5 million in 2025.
  • Business Quant data shows Non-Current Assets for TMCI at $58.5 million in Q4 2025, $58.6 million in Q3 2025, and $58.8 million in Q2 2025.